Target intelligence / Profile preview

Helicobacter pylori virulence factors and enzymes (H. pylori components)

Target
H. pylori components
Molecular classification
Enzyme, Adhesin, Toxin, Bacterial surface protein
01

Overview

Helicobacter pylori (H. pylori) utilizes a diverse array of surface proteins and enzymatic components to colonize the harsh, acidic environment of the human stomach and promote pathogenesis. Key components include the enzyme urease, which neutralizes gastric acid by producing ammonia, and various adhesins such as BabA and SabA that facilitate attachment to the gastric epithelium (Source: NIH, StatPearls). Additionally, virulence factors like the vacuolating cytotoxin A (VacA) and the cytotoxin-associated gene A (CagA) protein are secreted or injected into host cells to disrupt cellular integrity and induce pro-inflammatory signaling (Source: PubMed). These components are primary targets for therapeutic intervention, typically through multi-drug regimens involving antibiotics that inhibit bacterial protein or cell wall synthesis and bismuth-based compounds that disrupt bacterial membranes and enzyme activity (Source: Mayo Clinic). Eradication of H. pylori via these targets is essential for treating peptic ulcers and reducing the risk of gastric adenocarcinoma and MALT lymphoma (Source: World Journal of Gastroenterology).

Other names
H. pylori surface proteinsH. pylori enzymatic componentsHelicobacter pylori virulence factorsH. pylori adhesins and toxins
02

Mechanism of action

Inhibition of bacterial protein synthesis, cell wall synthesis, or DNA replication; neutralization of gastric acidity via urease inhibition; and disruption of bacterial cell membrane integrity and adherence.

03

Biological functions

Bacterial colonizationAcid neutralizationHost cell adhesionInduction of inflammationCytotoxicity
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Antibiotic resistanceGastrointestinal dysbiosisSystemic side effects of multi-drug therapyTreatment non-compliance
06

Interacting drugs

Clarithromycin

7 more in the full profile.

07

Biomarkers

Urea breath testStool antigen testRapid urease test (RUT)CagA serologyVacA serology

Beyond the preview

Go deeper on Helicobacter pylori virulence factors and enzymes (H. pylori components).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori virulence factors and enzymes (H. pylori components).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call